These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cross-immunity in Nile tilapia vaccinated with Streptococcus agalactiae and Streptococcus iniae vaccines. Wang Q, Fu T, Li X, Luo Q, Huang J, Sun Y, Wang X. Fish Shellfish Immunol; 2020 Feb; 97():382-389. PubMed ID: 31841691 [Abstract] [Full Text] [Related]
3. Efficacy of Streptococcus agalactiae (group B) vaccine in tilapia (Oreochromis niloticus) by intraperitoneal and bath immersion administration. Evans JJ, Klesius PH, Shoemaker CA. Vaccine; 2004 Sep 09; 22(27-28):3769-73. PubMed ID: 15315858 [Abstract] [Full Text] [Related]
4. Immune response and protective efficacy of two new adjuvants, Montanide™ ISA 763B VG and Montanide™ GEL02, administered with a Streptococcus agalactiae ghost vaccine in Nile tilapia (Oreochromis niloticus). Wangkaghart E, Deville S, Wang B, Srisapoome P, Wang T, Secombes CJ. Fish Shellfish Immunol; 2021 Sep 09; 116():19-29. PubMed ID: 34153428 [Abstract] [Full Text] [Related]
5. Characterization of novel antigenic vaccine candidates for nile tilapia (Oreochromis niloticus) against Streptococcus agalactiae infection. Ma Y, Hao L, Liang Z, Ma J, Ke H, Kang H, Yang H, Wu J, Feng G, Liu Z. Fish Shellfish Immunol; 2020 Oct 09; 105():405-414. PubMed ID: 32712231 [Abstract] [Full Text] [Related]
7. GapA, a potential vaccine candidate antigen against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus). Zhang Z, Yu A, Lan J, Zhang H, Hu M, Cheng J, Zhao L, Lin L, Wei S. Fish Shellfish Immunol; 2017 Apr 09; 63():255-260. PubMed ID: 28219739 [Abstract] [Full Text] [Related]
11. Oral vaccination of tilapia against Streptococcus agalactiae using Bacillus subtilis spores expressing Sip. Yao YY, Chen DD, Cui ZW, Zhang XY, Zhou YY, Guo X, Li AH, Zhang YA. Fish Shellfish Immunol; 2019 Mar 09; 86():999-1008. PubMed ID: 30590166 [Abstract] [Full Text] [Related]
12. Development of a vaccine against Streptococcus agalactiae in fish based on truncated cell wall surface anchor proteins. Liu H, Zhang S, Shen Z, Ren G, Liu L, Ma Y, Zhang Y, Wang W. Vet Rec; 2016 Oct 08; 179(14):359. PubMed ID: 27660279 [Abstract] [Full Text] [Related]
13. Phosphoglycerate kinase enhanced immunity of the whole cell of Streptococcus agalactiae in tilapia, Oreochromis niloticus. Wang YT, Huang HY, Tsai MA, Wang PC, Jiang BH, Chen SC. Fish Shellfish Immunol; 2014 Dec 08; 41(2):250-9. PubMed ID: 25218275 [Abstract] [Full Text] [Related]
14. Efficacy of live attenuated vaccine derived from the Streptococcus agalactiae on the immune responses of Oreochromis niloticus. Laith AA, Abdullah MA, Nurhafizah WWI, Hussein HA, Aya J, Effendy AWM, Najiah M. Fish Shellfish Immunol; 2019 Jul 08; 90():235-243. PubMed ID: 31009810 [Abstract] [Full Text] [Related]
15. The HSP70 and IL-1β of Nile tilapia as molecular adjuvants can enhance the immune protection of DNA vaccine against Streptococcus agalactiae infection. Xu FF, Deng ZY, Sheng JJ, Zhu B. J Fish Dis; 2024 Nov 08; 47(11):e14002. PubMed ID: 39075840 [Abstract] [Full Text] [Related]
16. Vaccine-induced antibody level as the parameter of the influence of environmental salinity on vaccine efficacy in Nile tilapia. Wang J, He RZ, Lu GL, Luo HL, Lu DQ, Li AX. Fish Shellfish Immunol; 2018 Nov 08; 82():522-530. PubMed ID: 30118846 [Abstract] [Full Text] [Related]
20. Development and efficacy of feed-based recombinant vaccine encoding the cell wall surface anchor family protein of Streptococcus agalactiae against streptococcosis in Oreochromis sp. Nur-Nazifah M, Sabri MY, Siti-Zahrah A. Fish Shellfish Immunol; 2014 Mar 08; 37(1):193-200. PubMed ID: 24486904 [Abstract] [Full Text] [Related] Page: [Next] [New Search]